1.
Meza Soto EA, Gomez-Lujan M, Velasco Espinal JE, et al. The Role of GLP-1 Receptor Agonists (Ozempic and Mounjaro) as Secondary Therapy in Chronic Kidney Disease. Rev. Cienc. Multidiscip. SAGA. 2025;2(3):973-991. doi:10.63415/saga.v2i3.257